Corixa [CRXA] - cancer vaccines Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Corixa [CRXA] - cancer vaccines

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andreas Helke who started this subject	2/28/2001 1:57:00 PM
From: berblady	Read Replies (1) of 222

Has anyone heard prior to this that the March review for Bexxar has been cancelled? The following is an excerpt copied from today's CBS Market Watch story: "Corixa has a great deal riding on the approval of Bexxar, which treats non-Hodgkin's lymphoma and is being reviewed by the FDA for marketing. Previous delays in the approval process and the cancellation of a March review by an FDA advisory panel have contributed to uncertainty about when the drug will be brought to market. Corixa is not planning on revenue from Bexxar in 2001, which is "curious" if the drug's approval and launch were anticipated this year, Tanner said."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next